National Cancer Institute Amended; Notice of Meeting, 8684 [2018-04017]
Download as PDF
<![CDATA[
8684
Federal Register / Vol. 83, No. 40 / Wednesday, February 28, 2018 / Notices
published in the Federal Register on
February 20, 2018, 83 FR 7201.
This meeting notice is amended to
change the meeting name from
‘‘Targeted Radiotherapy & RadiationInduced Toxicity’’ to ‘‘TEP–4: Targeted
Radiotherapy & Radiation-Induced
Toxicity’’. The meeting time has
changed from 12:00 p.m. to 4:00 p.m. to
12:30 p.m. to 4:30 p.m. The meeting is
closed to the public.
Dated: February 22, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–04015 Filed 2–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
February 22, 2018, 12:00 p.m. to
February 22, 2018, 03:00 p.m., National
Cancer Institute Shady Grove, 9609
Medical Center Drive, Rockville, MD
20850 which was published in the
Federal Register on January 24, 2018, 83
FR 3351.
This meeting notice is amended to
change the meeting date from February
22, 2018 to March 21, 2018. The
meeting is closed to the public.
Dated: February 22, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–04017 Filed 2–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, March
09, 2018, 10:00 a.m. to March 09, 2018,
12:00 p.m., National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD
20892 which was published in the
Federal Register on February 20, 2018,
83 FR 7199.
The meeting will be held on March 6,
2018, 10:00 a.m. to 12:30 p.m. The
meeting location remains the same. The
meeting is closed to the public.
VerDate Sep<11>2014
17:25 Feb 27, 2018
Jkt 244001
Dated: February 22, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–04014 Filed 2–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings. The meetings will
be closed to the public in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Nephrology Clinical
Trial Applications.
Date: March 19, 2018.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
ryan.morris@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity Research.
Date: March 20, 2018.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Planning and
Developmental Grants.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Date: March 23, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Precision Dietetics
to Improve Metabolic Health.
Date: March 23, 2018.
Time: 2:00 p.m. to 3:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Nephrology Clinical
Small Business Applications.
Date: March 28, 2018.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
ryan.morris@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Dissecting the
Pathogenesis an Outcomes of PSC using
Multi-omics by Studying the Exposome and
Genome.
Date: March 29, 2018.
Time: 1:00 p.m. to 2:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
E:\FR\FM\28FEN1.SGM
28FEN1
]]>Agencies
[Federal Register Volume 83, Number 40 (Wednesday, February 28, 2018)]
[Notices]
[Page 8684]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04017]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended; Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, February 22, 2018, 12:00 p.m.
to February 22, 2018, 03:00 p.m., National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Rockville, MD 20850 which was
published in the Federal Register on January 24, 2018, 83 FR 3351.
This meeting notice is amended to change the meeting date from
February 22, 2018 to March 21, 2018. The meeting is closed to the
public.
Dated: February 22, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-04017 Filed 2-27-18; 8:45 am]
BILLING CODE 4140-01-P
